Literature DB >> 3450293

Polarographic studies on the conformation of some platinum complexes: relations to anti-tumour activity.

O Vrána1, V Brabec, V Kleinwächter.   

Abstract

Conformational alterations induced in DNA by the binding of various bivalent and tetravalent platinum complexes were characterized by means of differential pulse polarography and circular dichroism spectroscopy. It was found that at low levels of binding the platination of DNA markedly influenced its polarographic behaviour. The results indicated that the binding of the active anti-tumour complexes resulted in minor conformational changes in DNA when the double-stranded structure remained conserved. On the other hand, the attack by inactive anti-tumour compounds induced more severe alterations which had the character of denaturation of longer regions of the DNA molecule. It was also demonstrated that active anti-tumour tetravalent platinum complexes could react with DNA, without their prior reduction to the bivalent state, and may induce in DNA conformational changes similar to those produced by bivalent cisplatin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3450293

Source DB:  PubMed          Journal:  Anticancer Drug Des        ISSN: 0266-9536


  12 in total

1.  Antitumor bifunctional dinuclear Pt(II) complex BBR3535 forms interduplex DNA cross-links under molecular crowding conditions.

Authors:  Tereza Muchova; Susana M Quintal; Nicholas P Farrell; Viktor Brabec; Jana Kasparkova
Journal:  J Biol Inorg Chem       Date:  2011-09-21       Impact factor: 3.358

2.  Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog.

Authors:  Jaroslav Malina; Olga Novakova; Marie Vojtiskova; Giovanni Natile; Viktor Brabec
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

3.  Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand.

Authors:  Yousef Najajreh; Jana Kasparkova; Victoria Marini; Dan Gibson; Viktor Brabec
Journal:  J Biol Inorg Chem       Date:  2005-11-08       Impact factor: 3.358

4.  Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.

Authors:  Hana Kostrhunova; Jaroslav Malina; Amanda J Pickard; Jana Stepankova; Marie Vojtiskova; Jana Kasparkova; Tereza Muchova; Matthew L Rohlfing; Ulrich Bierbach; Viktor Brabec
Journal:  Mol Pharm       Date:  2011-08-17       Impact factor: 4.939

Review 5.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

6.  Studies on the human metabolism of iproplatin.

Authors:  L Pendyala; B S Krishnan; J R Walsh; A V Arakali; J W Cowens; P J Creaven
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  Effects of monofunctional adducts of platinum(II) complexes on thermodynamic stability and energetics of DNA duplexes.

Authors:  Vendula Bursova; Jana Kasparkova; Ctirad Hofr; Viktor Brabec
Journal:  Biophys J       Date:  2004-12-01       Impact factor: 4.033

8.  Biophysical studies on the stability of DNA intrastrand cross-links of transplatin.

Authors:  Jana Kasparkova; Victoria Marini; Vendula Bursova; Viktor Brabec
Journal:  Biophys J       Date:  2008-08-01       Impact factor: 4.033

9.  Conformation and recognition of DNA modified by a new antitumor dinuclear PtII complex resistant to decomposition by sulfur nucleophiles.

Authors:  Lenka Zerzankova; Tereza Suchankova; Oldrich Vrana; Nicholas P Farrell; Viktor Brabec; Jana Kasparkova
Journal:  Biochem Pharmacol       Date:  2009-08-12       Impact factor: 5.858

10.  DNA and glutathione interactions in cell-free media of asymmetric platinum(II) complexes cis- and trans-[PtCl2(isopropylamine)(1-methylimidazole)]: relations to their different antitumor effects.

Authors:  Tereza Suchánková; Marie Vojtísková; Jan Reedijk; Viktor Brabec; Jana Kaspárková
Journal:  J Biol Inorg Chem       Date:  2008-09-06       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.